Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR4 | Q13639 | 3/20 | 0.43 |
| ▸ | F10 | P00742 | 10/20 | 0.42 |
| ▸ | EP300 | Q09472 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | HTR6 | P50406 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25016025 | 0.88 | F10 (0.45) | HTR4F10 | |
| SCHEMBL21822848 | 0.87 | F10 (0.51) | HTR4F10 | |
| SCHEMBL28593853 | 0.85 | HTR6 (0.44) | HTR4F10PPARGHTR6 | |
| SCHEMBL25017145 | 0.80 | F10 (0.46) | F10 | |
| SCHEMBL25017559 | 0.80 | F10 (0.46) | F10 | |
| SCHEMBL25016195 | 0.80 | F10 (0.45) | F10 | |
| SCHEMBL25016287 | 0.80 | F10 (0.45) | F10 | |
| SCHEMBL25016018 | 0.79 | HTR4 (0.46) | HTR4EP300PPARG | |
| SCHEMBL25016818 | 0.78 | F10 (0.50) | F10 | |
| SCHEMBL21822156 | 0.78 | CCR2 (0.52) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230043159-A1 | MATRIPTASE 2 INHIBITORS AND USES THEREOF | DISC MEDICINE, INC. | 2023-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230043159-A1 | MATRIPTASE 2 INHIBITORS AND USES THEREOF | MMP7, MATR3, SPINT2 | HTR4 1691/4885F10 1548/4885EP300 3582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.